Is PRM a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Perimeter Solutions (PRM) rests on A contracted federal retardant franchise: Fire Safety is not a spot-market chemicals business. The bear case rests on the founder advisory structure is the single largest non-operating claim on this company: at June 30, 2026 the fixed amount was carried at ~$167.5 million and the variable amount at ~$1,093.6 million, roughly ~$1.26 billion combined against a ~$5.15 billion market value, with ~$630.6 million already sitting on the balance sheet as a related-party liability and ~$95.7 million settled in cash during the first half of 2026, and because at least half is settled in shares it dilutes as well as costs. Analysts covering it publish targets from $40.00 to $48.00 against a $31.44 price, so even the professionals disagree by 18% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Perimeter Solutions, Inc. (NYSE: PRM) is a Clayton, Missouri industrial company that runs two reporting segments. Fire Safety formulates and manufactures aerial long-term fire retardants and fire suppressant foams, and it supplies the equipment and the resupply service network behind them, covering roughly ~150 air tanker bases across North America. That segment produced ~$489.0 million of net sales and ~$290.5 million of segment adjusted EBITDA in fiscal 2025, a margin near ~59%, and it sits on top of contracts rather than open-market demand: a sole-source USDA Forest Service aerial retardant award announced in September 2025 with a potential value of ~$1.12 billion over five years, a CAL FIRE renewal covering 2026 to 2031 with pricing brought in line with other large retardant customers, and a Defense Logistics Agency indefinite-delivery contract for aqueous film forming foam with a ~$500 million ceiling and an ordering period running to April 29, 2031. Specialty Products is the other half of the story and is being built by purchase: lubricant additives through Phosphorus Derivatives (phosphorus pentasulfide), electronic and electro-mechanical components through Intelligent Manufacturing Solutions, electro-optical product lines bought for ~$40.0 million in November 2025, Medical Manufacturing Technologies acquired from Arcline for ~$685 million in January 2026, and Monaco Enterprises, a life safety and emergency management systems supplier to US government facilities, for ~$120.0 million on July 30, 2026. The investment picture turns on three things that do not show up in a screener. First, the seasonality is extreme, because retardant demand tracks the wildfire season: quarterly net sales ran ~$102.8 million in Q4 2025, ~$125.1 million in Q1 2026, ~$213.8 million in Q2 2026 and ~$315.4 million in Q3 2025, so a trailing-twelve-month figure blends a peak quarter with two near-dormant ones and tells you very little about a run rate. Second, the company assumed an advisory agreement from EverArc Holdings, the vehicle that took it public in November 2021, under which EverArc Founders, LLC receives a fixed annual amount of ~2,357,061 shares per year through 2027 and a variable amount tied to share-price appreciation through 2031. Half of that is liability-classified and remeasured every quarter, so the stock rising ~71% over the past year produced a ~$266.3 million founders advisory expense in Q2 2026 alone and a ~$1.26 billion combined fair value at June 30, 2026. Third, the balance sheet changed shape in 2026: gross borrowings went from ~$675 million to ~$1.225 billion to fund MMT, cash fell from ~$325.9 million to ~$82.8 million, and goodwill plus intangibles now stand at roughly ~$2.59 billion of ~$3.24 billion in total assets. At ~$31.44 per share in late August 2026 the market value is ~$5.15 billion and enterprise value ~$6.44 billion, or about ~17.5x trailing adjusted EBITDA and ~18.5x forward earnings.

The bull case: what would have to be true for $48.00

The most optimistic published target on PRM is $48.00, +52.7% from the $31.44 price as of August 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. A contracted federal retardant franchise

Fire Safety is not a spot-market chemicals business. The USDA Forest Service award announced in September 2025 carries a potential value of ~$1.12 billion over five years on a sole-source basis, and it comes with obligations that raise the barrier behind Perimeter: transitioning federal aerial firefighting to powder retardant, upgrading tanker base capacity, and taking over full-service operations at most or all federal bases. The CAL FIRE renewal covering 2026 to 2031 added price increases that align California with other large customers, which is part of why Fire Safety adjusted EBITDA margin expanded from ~27% to ~41% in Q1 2026. Volume still depends on how bad a fire season is, but pricing and share are locked down further out than they were two years ago.

2. Specialty Products as the deliberate second leg

Management has spent heavily to make the company something other than a one-season business. Specialty Products net sales rose ~113% to ~$164.4 million in the first half of 2026 and segment adjusted EBITDA rose ~127% to ~$49.3 million, almost entirely because of purchased businesses rather than organic growth. Medical Manufacturing Technologies, bought for ~$685 million in January 2026, makes engineered machinery and aftermarket consumables for minimally invasive medical device production, with roughly half its revenue from aftermarket, a materially different demand pattern from wildfire retardant. Monaco Enterprises, closed July 30, 2026 for ~$120.0 million, is expected to contribute more than ~$11 million of annualized adjusted EBITDA, which the company framed as a purchase multiple near ~10.5x.

3. The Defense Logistics Agency foam contract ramping into 2027

The DLA fixed-price indefinite-delivery contract for aqueous film forming foam has a ~$500 million ceiling, serves the Army, Navy and Coast Guard, and runs through an ordering period ending April 29, 2031. Perimeter has described it as roughly ~$300 million of incremental revenue above its existing DLA business, beginning to ramp in late 2026. That is a revenue stream that arrives on a defense procurement cadence rather than a fire season, which is the diversification argument in its most concrete form. Ceilings on indefinite-delivery contracts are maximums and not commitments, so the realized figure depends on ordering behavior.

4. Capital allocation is the stated operating model

Perimeter runs an explicitly capital-allocation-led model inherited from EverArc, with decentralized operations, a named set of internal Value Drivers and a stated intent to keep buying niche businesses. In 2026 that meant ~$682.3 million of acquisition spend in the first half, funded by ~$550 million of new senior secured notes due 2034 on top of ~$675 million of 2029 notes, leaving the ~$200 million revolving facility fully undrawn at June 30, 2026. The company has bought back stock before (~$40.4 million in the first half of 2025, ~$168.2 million of treasury stock at cost on the balance sheet) but repurchased nothing in the first half of 2026, having redirected cash into deals. Whether the model compounds depends on paying reasonable multiples for businesses with aftermarket or contracted revenue, which is what both 2026 deals were pitched as.

The bear case: what would have to be true for $40.00

The most pessimistic published target is $40.00, +27.2% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Perimeter Solutions is worth if the risks below bite instead of the drivers above.

The founder advisory structure is the single largest non-operating claim on this company: at June 30, 2026 the fixed amount was carried at ~$167.5 million and the variable amount at ~$1,093.6 million, roughly ~$1.26 billion combined against a ~$5.15 billion market value, with ~$630.6 million already sitting on the balance sheet as a related-party liability and ~$95.7 million settled in cash during the first half of 2026, and because at least half is settled in shares it dilutes as well as costs. Customer concentration is severe and stated plainly in the filings, with substantial dependence on the USDA Forest Service, the Bureau of Land Management and the State of California, so a contract loss, a procurement change or a mild fire season hits a business with very high incremental margins in both directions. Leverage rose sharply in 2026 to ~$1.225 billion of notes against ~$82.8 million of cash and ~$369 million of trailing adjusted EBITDA, and operating cash flow was negative ~$89.6 million in the first half because of the founder fee settlement and a seasonal working capital build, which is normal for the cycle but leaves less room if a season disappoints. Perimeter is named in the aqueous film forming foam multi-district litigation consolidated in the District of South Carolina and in similar matters elsewhere; the company states that losses are not considered probable or reasonably estimable at this time, and separately the Schall Law Firm publicized an investigation of the company in April 2026, which is a plaintiff-firm announcement rather than a filed case with a docket number. Finally, ~$1.37 billion of goodwill and ~$1.22 billion of intangibles now dominate the asset side, so an acquisition that underperforms shows up as an impairment rather than as a slow fade in revenue.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding PRM already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on PRM

4 analysts cover PRM, with an average target of $43.75 (+39.2% against $31.44) and a split of 4 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the PRM forecast and price target page.

How is PRM valued? (as of August 2026)

Price
$31.44
Market cap
$5.15B
Forward P/E
17.14
Price / book
5.04
Beta
1.91
52-week range
$19.70 to $38.17

Snapshot for PRM as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$757.1 million trailing twelve months (up ~24%); fiscal 2025 net sales ~$652.9 million (up ~16%); first half 2026 ~$338.9 million (up ~44%), split Fire Safety ~$174.5 million and Specialty Products ~$164.4 million
  • Earnings (GAAP): Trailing net loss ~$339.6 million; Q2 2026 net loss ~$181.6 million (~-$1.11 per diluted share) versus ~$32.2 million a year earlier; fiscal 2025 net loss ~$206.4 million (~-$1.37). The swing is driven by ~$266.3 million of founders advisory fee expense in Q2 2026 alone
  • Adjusted profitability: Q2 2026 adjusted EBITDA ~$105.6 million (up ~16%) and adjusted EPS ~$0.35 (versus ~$0.39 and below the ~$0.42 consensus); first half adjusted EBITDA ~$146.7 million (up ~34%); fiscal 2025 adjusted EBITDA ~$331.7 million, implying roughly ~$369 million trailing
  • Seasonality: Quarterly net sales ran ~$102.8 million (Q4 2025), ~$125.1 million (Q1 2026), ~$213.8 million (Q2 2026) and ~$315.4 million in the peak Q3 2025, so any trailing-twelve-month multiple mixes one fire-season quarter with three quiet ones
  • Balance sheet: ~$82.8 million cash (down from ~$325.9 million at year-end) against ~$1.225 billion of notes (~$675 million due 2029, ~$550 million due 2034) and an undrawn ~$200 million revolver; ~$630.6 million of founders advisory fees payable; ~$119.0 million of 6.50% redeemable preferred; ~$1.37 billion goodwill and ~$1.02 billion of equity on ~$3.24 billion of assets
  • Market pricing: ~$31.44 per share for a market value near ~$5.15 billion on ~163.7 million shares and an enterprise value near ~$6.44 billion: about ~6.8x sales, ~8.5x EV to sales, ~17.5x trailing adjusted EBITDA, ~18.5x forward earnings and ~5.0x book. 52-week range ~$18.41 to ~$38.17, beta ~1.91, short interest ~3.1% of shares. Four covering analysts average a ~$43.75 target

Figures are approximate, stamped to August 2026 and drawn from the Q2 2026 10-Q, the July 31, 2026 earnings release and the fiscal 2025 10-K, so check live data before acting on any of them. Two adjustments matter more here than at most companies: trailing GAAP earnings are not usable because the founders advisory remeasurement moves with the share price, so a rising stock mechanically manufactures a larger loss, and a trailing revenue or EBITDA multiple understates seasonality because Q3 alone can carry more revenue than the two adjacent quarters combined. Consensus has fiscal 2026 revenue near ~$881.5 million and EPS near ~$1.55, rising to ~$995.5 million and ~$1.83 in 2027, which embeds both a full year of Medical Manufacturing Technologies and the start of the DLA foam ramp.

How do you decide if PRM is a buy?

Rather than asking whether PRM is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold PRM indirectly through an index or sector ETF before adding more.

What would change your mind on PRM

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: A contracted federal retardant franchise stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: the founder advisory structure is the single largest non-operating claim on this company: at June 30, 2026 the fixed amount was carried at ~$167.5 million and the variable amount at ~$1,093.6 million, roughly ~$1.26 billion combined against a ~$5.15 billion market value, with ~$630.6 million already sitting on the balance sheet as a related-party liability and ~$95.7 million settled in cash during the first half of 2026, and because at least half is settled in shares it dilutes as well as costs fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the PRM stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about PRM against your real portfolio and see your actual exposure before deciding.

Investing in Perimeter Solutions with AI

Connect the broker you already use and ask Walnut's AI how PRM fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is PRM a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on A contracted federal retardant franchise, with revenue (ttm) at ~$757.1 million trailing twelve months (up ~24%); fiscal 2025 net sales ~$652.9 million (up ~16%); first half 2026 ~$338.9 million (up ~44%), split Fire Safety ~$174.5 million and Specialty Products ~$164.4 million. The bear case rests on the founder advisory structure is the single largest non-operating claim on this company: at June 30, 2026 the fixed amount was carried at ~$167.5 million and the variable amount at ~$1,093.6 million, roughly ~$1.26 billion combined against a ~$5.15 billion market value, with ~$630.6 million already sitting on the balance sheet as a related-party liability and ~$95.7 million settled in cash during the first half of 2026, and because at least half is settled in shares it dilutes as well as costs. Analysts covering it are spread from $40.00 to $48.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell PRM?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The founder advisory structure is the single largest non-operating claim on this company: at June 30, 2026 the fixed amount was carried at ~$167.5 million and the variable amount at ~$1,093.6 million, roughly ~$1.26 billion combined against a ~$5.15 billion market value, with ~$630.6 million already sitting on the balance sheet as a related-party liability and ~$95.7 million settled in cash during the first half of 2026, and because at least half is settled in shares it dilutes as well as costs. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $40.00, +27.2% from the $31.44 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for PRM?

+

A contracted federal retardant franchise. Fire Safety is not a spot-market chemicals business. The most optimistic analyst target on PRM is $48.00, +52.7% from the $31.44 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for PRM?

+

The founder advisory structure is the single largest non-operating claim on this company: at June 30, 2026 the fixed amount was carried at ~$167.5 million and the variable amount at ~$1,093.6 million, roughly ~$1.26 billion combined against a ~$5.15 billion market value, with ~$630.6 million already sitting on the balance sheet as a related-party liability and ~$95.7 million settled in cash during the first half of 2026, and because at least half is settled in shares it dilutes as well as costs. Customer concentration is severe and stated plainly in the filings, with substantial dependence on the USDA Forest Service, the Bureau of Land Management and the State of California, so a contract loss, a procurement change or a mild fire season hits a business with very high incremental margins in both directions. Leverage rose sharply in 2026 to ~$1.225 billion of notes against ~$82.8 million of cash and ~$369 million of trailing adjusted EBITDA, and operating cash flow was negative ~$89.6 million in the first half because of the founder fee settlement and a seasonal working capital build, which is normal for the cycle but leaves less room if a season disappoints. Perimeter is named in the aqueous film forming foam multi-district litigation consolidated in the District of South Carolina and in similar matters elsewhere; the company states that losses are not considered probable or reasonably estimable at this time, and separately the Schall Law Firm publicized an investigation of the company in April 2026, which is a plaintiff-firm announcement rather than a filed case with a docket number. Finally, ~$1.37 billion of goodwill and ~$1.22 billion of intangibles now dominate the asset side, so an acquisition that underperforms shows up as an impairment rather than as a slow fade in revenue. The most pessimistic published target is $40.00, +27.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Perimeter Solutions do?

+

Perimeter Solutions makes the aerial fire retardants and suppressant foams federal firefighting agencies buy, plus a specialty products arm being assembled through acquisitions.

What would have to change for PRM to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (A contracted federal retardant franchise) stalling in the reported numbers rather than in the narrative, the risk above (the founder advisory structure is the single largest non-operating claim on this company: at June 30, 2026 the fixed amount was carried at ~$167.5 million and the variable amount at ~$1,093.6 million, roughly ~$1.26 billion combined against a ~$5.15 billion market value, with ~$630.6 million already sitting on the balance sheet as a related-party liability and ~$95.7 million settled in cash during the first half of 2026, and because at least half is settled in shares it dilutes as well as costs) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Perimeter Solutions actually do?

+

It runs two segments. Fire Safety formulates and manufactures aerial long-term fire retardants and fire suppressant foams, and supplies the airbase storage, mixing and delivery equipment, mobile retardant bases and the emergency resupply network behind them, serving roughly ~150 air tanker bases across North America plus customers globally. Specialty Products covers non-fire markets: phosphorus pentasulfide-based lubricant additives through Phosphorus Derivatives, electronic and electro-mechanical components through Intelligent Manufacturing Solutions, and, since January 2026, engineered machinery and aftermarket consumables for minimally invasive medical device manufacturing through Medical Manufacturing Technologies. Fire Safety was ~$489.0 million of the ~$652.9 million of fiscal 2025 net sales.

Why does Perimeter report a large net loss while adjusted EBITDA keeps rising?

+

Because of a related-party expense that is not an operating cost. Perimeter assumed an advisory agreement under which EverArc Founders, LLC earns amounts tied to the share price, and the half that could be settled in cash is remeasured at fair value every quarter. When the stock rises, that liability grows and the increase flows through the income statement as founders advisory fee expense. In Q2 2026 that line was ~$266.3 million, which turned ~$117.9 million of gross profit into an operating loss of ~$203.0 million and a net loss of ~$181.6 million. Adjusted EBITDA, which excludes it, rose ~16% to ~$105.6 million in the same quarter. The mechanical consequence is that a strong share price produces a larger reported loss, which is the opposite of the usual relationship.

How large is the founder advisory obligation and when does it end?

+

It is large enough to be a material part of the capital structure. The agreement, entered into by EverArc Holdings in December 2019 and assumed by Perimeter in 2021, pays a Fixed Annual Advisory Amount equal to ~2,357,061 shares (~1.5% of the ~157,137,410 shares outstanding at the November 2021 combination) each year through December 31, 2027, plus a Variable Annual Advisory Amount tied to share-price appreciation through December 31, 2031. At June 30, 2026 the fixed piece was valued at ~$167.5 million and the variable piece at ~$1,093.6 million using a Monte Carlo model, roughly ~$1.26 billion combined. At least half is settled in shares at the founder entity's election, so it is both a cash cost and a dilution source. William N. Thorndike, Jr., an EverArc co-founder, filed a Schedule 13D in March 2026 reporting ~9,309,341 shares, or ~5.7% of the class.

Walnut is informational, not investment advice, and gives no verdict on PRM. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Related stocks

    Is PRM a Buy or a Sell? The Bull and Bear Case (2026) - Walnut AI Investing App